KR20150035730A - 커큐민을 함유하는 개선된 복합체 및 조성물 - Google Patents

커큐민을 함유하는 개선된 복합체 및 조성물 Download PDF

Info

Publication number
KR20150035730A
KR20150035730A KR20147036049A KR20147036049A KR20150035730A KR 20150035730 A KR20150035730 A KR 20150035730A KR 20147036049 A KR20147036049 A KR 20147036049A KR 20147036049 A KR20147036049 A KR 20147036049A KR 20150035730 A KR20150035730 A KR 20150035730A
Authority
KR
South Korea
Prior art keywords
composition
complex
curcumin
oil
phospholipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR20147036049A
Other languages
English (en)
Korean (ko)
Inventor
해럴드 고든 케이브
Original Assignee
해럴드 고든 케이브
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 해럴드 고든 케이브 filed Critical 해럴드 고든 케이브
Publication of KR20150035730A publication Critical patent/KR20150035730A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR20147036049A 2012-05-22 2013-05-22 커큐민을 함유하는 개선된 복합체 및 조성물 Ceased KR20150035730A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ600146 2012-05-22
NZ60014612 2012-05-22
PCT/NZ2013/000086 WO2013176555A1 (en) 2012-05-22 2013-05-22 Improved complexes and compositions containing curcumin

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020197021718A Division KR20190090075A (ko) 2012-05-22 2013-05-22 커큐민을 함유하는 개선된 복합체 및 조성물

Publications (1)

Publication Number Publication Date
KR20150035730A true KR20150035730A (ko) 2015-04-07

Family

ID=49624145

Family Applications (2)

Application Number Title Priority Date Filing Date
KR20147036049A Ceased KR20150035730A (ko) 2012-05-22 2013-05-22 커큐민을 함유하는 개선된 복합체 및 조성물
KR1020197021718A Ceased KR20190090075A (ko) 2012-05-22 2013-05-22 커큐민을 함유하는 개선된 복합체 및 조성물

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020197021718A Ceased KR20190090075A (ko) 2012-05-22 2013-05-22 커큐민을 함유하는 개선된 복합체 및 조성물

Country Status (10)

Country Link
US (1) US20150104503A1 (enExample)
EP (2) EP3666265A1 (enExample)
JP (1) JP6211603B2 (enExample)
KR (2) KR20150035730A (enExample)
CN (3) CN110870857A (enExample)
AU (1) AU2013264466B2 (enExample)
CA (1) CA2910089A1 (enExample)
HK (1) HK1208375A1 (enExample)
IN (1) IN2014MN02552A (enExample)
WO (1) WO2013176555A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102013220974A1 (de) * 2013-10-16 2015-04-16 Briu Gmbh Zusammensetzung zur oralen Administration von Curcumin
JP6987528B2 (ja) * 2017-05-12 2022-01-05 小林製薬株式会社 クルクミノイド含有錠剤
CN109589410B (zh) * 2018-12-26 2022-02-01 晨光生物科技集团股份有限公司 一种姜黄素制剂及其制备方法
CN109846865B (zh) * 2018-12-26 2022-03-25 晨光生物科技集团股份有限公司 一种姜黄素制剂及其制备方法
KR102169710B1 (ko) * 2020-01-08 2020-10-26 제주대학교 산학협력단 커큐민 나노스피어, 그 제조방법 및 이의 용도
JP7471690B2 (ja) * 2020-04-10 2024-04-22 シャンハイ・ライトン・バイオケミカルズ・リミテッド 視覚疲労を軽減するための可食性組成物
CN115461050B (zh) * 2020-09-11 2023-11-28 李宗谚 药学组合物及其于治疗肌少症的用途
EP4251136A1 (en) * 2020-11-24 2023-10-04 Specchiasol S.r.l. Formulation for oral administration of active compounds with low bioavailability and corresponding production method
KR102488134B1 (ko) * 2021-09-28 2023-01-13 (주)바이노텍 입자 표면이 개질된 커큐민 나노 입자 복합체 및 이의 제조 방법
WO2023119230A1 (en) 2021-12-22 2023-06-29 L'oreal Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
EP4493170A1 (en) * 2022-02-28 2025-01-22 Gidaa Life Sciences Pvt. Ltd. A phytoactive encapsulated formulation for neurodegenerative diseases
CN115813780B (zh) * 2022-03-30 2024-08-13 广东格烯生物科技股份有限公司 一种含四氢姜黄素的纳米级祛黄组合物及其制备方法
IT202200025767A1 (it) 2022-12-15 2024-06-15 Prolabin & Tefarm S R L Formulazione comprendente polifenoli vanilloidi supportati su solidi lamellari per ridurre i livelli plasmatici di CGRP e sue applicazioni.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1201149B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
CN1283237C (zh) * 2004-11-22 2006-11-08 山东大学 姜黄素磷脂复合物及其制备方法
PL1871399T3 (pl) 2005-04-18 2011-09-30 Sc Dicophar Zastosowanie lecytyny jako leku w leczeniu łuszczycy
WO2007098118A2 (en) * 2006-02-16 2007-08-30 Byron Robinson Pharmaceutical, Inc. Antineoplastic and curcumin derivatives and methods of preparation and use
PL1993365T3 (pl) * 2006-03-06 2013-10-31 Univ California Preparaty z biodostępnych kurkuminoidów do leczenia choroby alzheimera oraz innych zaburzeń powiązanych z wiekiem
EP1837030A1 (en) * 2006-03-09 2007-09-26 INDENA S.p.A. Phospholipid complexes of curcumin having improved bioavailability
CA2657769C (en) * 2006-07-19 2014-11-18 The Board Of Regents Of The University Of Texas System Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease
IT1395086B1 (it) * 2009-03-11 2012-09-05 Velleja Res Srl Composizioni comprendenti curcumina in forma complessata con fosfolipidi e piperina ad azione chemio-sensibilizzante

Also Published As

Publication number Publication date
CN111407752A (zh) 2020-07-14
EP2852395A4 (en) 2015-12-16
CA2910089A1 (en) 2013-11-28
CN104540515A (zh) 2015-04-22
EP3666265A1 (en) 2020-06-17
US20150104503A1 (en) 2015-04-16
JP2015518862A (ja) 2015-07-06
HK1208375A1 (en) 2016-03-04
CN110870857A (zh) 2020-03-10
AU2013264466B2 (en) 2017-09-07
JP6211603B2 (ja) 2017-10-11
EP2852395A1 (en) 2015-04-01
WO2013176555A1 (en) 2013-11-28
AU2013264466A2 (en) 2016-01-21
AU2013264466A1 (en) 2015-01-22
KR20190090075A (ko) 2019-07-31
IN2014MN02552A (enExample) 2015-07-24

Similar Documents

Publication Publication Date Title
KR20150035730A (ko) 커큐민을 함유하는 개선된 복합체 및 조성물
JP2015518862A5 (enExample)
US5925669A (en) Carrier compositions for anti-neoplastic drugs
US6743930B2 (en) Kernel oil from plant kernel, process for extracting same, pharmaceutical composition and thereof
US20070122452A1 (en) Fat composition
FR2904554A1 (fr) Lipides moleculaires heterogenes cytotropes (lmhc), procede de preparation, et methodes de traitement de patients proteurs de cancers multiples
CN101194919A (zh) 沙棘籽油脂肪乳注射液及制备工艺
US20150110866A1 (en) Complexes and compositions containing curcumin
JP2007504197A (ja) ホスファチジルセリン塩基の生理学的活性組成物
CN100384436C (zh) 非肠道顺铂乳剂
WO2021156385A1 (en) Lipid composition comprising omega-3 fatty acids
JP4167849B2 (ja) 植物の果実から抽出した果実油、その抽出方法、医薬組成物およびその用途
CN103859395A (zh) 一种高吸收率的辅酶q10的自乳化释药体系及其制备方法及应用
EP3206677A1 (en) Monounsaturated fatty acid compositions and use for treating atherosclerosis
NZ610906A (en) Improved complexes and compositions containing curcumin
NZ610906B (en) Improved complexes and compositions containing curcumin
JP4969989B2 (ja) リン脂質組成物およびこれを含有する食品組成物、医薬品組成物、並びにその製造方法
CN110139645A (zh) 用于预防和/或治疗恶病质的ω-3脂肪酸组合物
PL217762B1 (pl) Kompozycja gęstego ekstraktu z igieł sosnowych do enkapsulacji
WO2007046386A1 (ja) 有用リン脂質組成物を含む機能性素材及び機能性食品
RU2285535C2 (ru) Косточковое масло из косточек плодов растений, способ его экстрагирования, фармацевтические композиции и их применение
CN107232324B (zh) 一种含有大豆磷脂的健康平衡油及其制备方法和用途
RU2520695C1 (ru) Комплекс биологически активных веществ для лечения и профилактики заболеваний сердечно-сосудистой системы
EP3579829A1 (en) Long-term efficacy of liver disease treatment with epa and dha
ITMI951210A1 (it) Nuovi derivati dell'alfa-tocoferolo e composizioni farmaceutiche che li contengono quali principi attivi

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20141222

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
A302 Request for accelerated examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20180409

Comment text: Request for Examination of Application

PA0302 Request for accelerated examination

Patent event date: 20180409

Patent event code: PA03022R01D

Comment text: Request for Accelerated Examination

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20180809

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20190424

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20180809

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20190724